Business & Economics

Board of Directors discussing different issues.

Sutro Biopharma Appoints Former Biogen Idec Executive Connie Matsui as Board Chair

Sutro Biopharma confirmed that the company has appointed Ms. Connie L. Matsui, retired Executive Vice President of Biogen Idec,...

Piramal Invests US $10 Million to Expand and Enhance High Potency API Capability

Piramal Pharma Solutions, a Contract Development and Manufacturing Organization (CDMO), confirmed the Grand Opening of a area of it's...
Photo: Piramal combines individualized service with unparalleled speed and flexibility to manufacture parenteral drug products in liquid and lyophilized dosage forms. Unique mobile isolator technology within FDA-approved sterile manufacturing facility ensures product containment for potent and cytotoxic compounds and radio-labeled products. Photo courtesy: Piramal Pharma Solutions/Coldstream Laboratories, Lexington, Kentucky.

Frost & Sullivan Recognizes Piramal for its End-to-End Integrated Services Across the Entire Drug...

Following a recent analysis of the market of contract development and manufacturing organizations (CDMO), Frost & Sullivan recognized Piramal...

MabPlex International Appoints Dr. Wei Chen as Chief Executive Officer

MabPlex International, a leading and fully integrated global Contract Development and Manufacturing Organization (CDMO) serving the global biopharmaceutical and...
Featured Image: Cancer cell Courtesy: © 2018. Fotolia. Used with permission.

FDA Grants Accelerated Approval of Polatuzumab Vedotin in Select Patients

The U.S. Food and Drug Administration (FDA) today confirmed that it has granted accelerated approval of polatuzumab vedotin-piiq (Polivy™;...
Scientist pipetting

ADC Therapeutics Expands Agreement with Synaffix

The Netherlands-based biotechnology company Synaffix, which develops clinical-stage technologies for the development of best-in-class antibody-drug conjugates or ADCs, confirmed...

Ado-trastuzumab emtansine Approved for the Treatment of Early Breast Cancer

In early May 2019, the United States Food and Drug Administration (FDA) approved ado-trastuzumab emtansine (Kadcyla®, Genentech/Roche; T-DM1) for...
Photo: Exhibition - Bird's Eye Overview. The 15th annual PEGS: The Essential Protein Engineering Summit brought more than 2,700 world-renowned experts, visionaries, and influencers from top pharma, biotech, academic, and government institutions to the Seaport World Trade Center in Boston, MA this past April 8-12, 2019, setting record-breaking attendance. Photo courtesy: CHI/PEGS

PEGS 2019: Using Economic Modelling In the ADC Manufacturing Supply Chain

Antibody-drug conjugates have become a strong and promising strategy for the treatment of cancer, and, potentially emerging in therapeutic...
Featured Image: Scientist in Biomedical Laboratory. Courtesy 2019 Fotolia. used with permission.

Femtogenix Signs License Agreement with Iksuda Therapeutics

Iksuda Therapeutics, formerly known as Glythera, confirmed that it has signed a licensing agreement with Femtogenix. The agreement gives...

Investment Company Cobepa Acquires BioAgilytix

BioAgilytix, a large molecule bioanalytical testing services, confirmed the agreement to be acquired by Cobepa S.A., a privately-held investment...